Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
about
Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspectsApricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.Overexpression of homeobox B-13 correlates with angiogenesis, aberrant expression of EMT markers, aggressive characteristics and poor prognosis in pancreatic carcinomaEstablishment and characterization of new cell lines of anaplastic pancreatic cancer, which is a rare malignancy: OCUP-A1 and OCUP-A2.CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.Changes in the in vitro activity of platinum drugs when administered in two aliquots.Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer.Prognostic Evaluation of Vimentin Expression in Correlation with Ki67 and CD44 in Surgically Resected Pancreatic Ductal Adenocarcinoma.The aberrant overexpression of vimentin is linked to a more aggressive status in tumours of the gastrointestinal tract.Form follows function: Morphological and immunohistological insights into epithelial-mesenchymal transition characteristics of tumor buds.Epigenetic control of epithelial-mesenchymal-transition in human cancer.Epithelial-to-mesenchymal transition: immunohistochemical investigation of related molecules in canine cutaneous epithelial tumours.Blind SELEX Approach Identifies RNA Aptamers That Regulate EMT and Inhibit Metastasis.A and B blood group antigens in human pancreatic ductal adenocarcinomas.Cytopathological and immunocytochemical findings of pancreatic anaplastic carcinoma with ZEB1 expression by means of touch imprint cytology.EGFR expression in pancreatic adenocarcinoma. Relationship to tumour morphology and cell adhesion proteins.
P2860
Q28066454-99049C0B-33F5-4F23-962E-E9DC99975264Q33801377-982FB6E6-FE45-4080-A62E-29B775FC652FQ34290118-5E79E214-0EA8-4B36-BE66-A61F1DAD4237Q35919196-B1BA13F2-72FE-463B-9B23-48C58B50AF36Q35986433-6C88E86E-2263-403C-8862-DDFF9D700DC9Q36037993-761A3A7D-BBDB-48B0-9C9D-F187968200B4Q36114723-D3AF5E4A-3B52-4051-92F8-30B2E3D76D40Q37075334-7B52A4DC-7686-49B5-9C32-F1DA4284A2EAQ37573308-E2412443-9CDB-46FC-871F-91FD3163CD04Q37738137-03116D29-3C2F-4915-AE38-EC341D63EE32Q38471210-8463789B-9838-419F-9275-BA023411930DQ38704747-EF074C30-16A4-41A3-8B22-D0A1A30C69D8Q42409031-D15C8D84-42E4-4E60-A3EE-83D6AAD346ECQ45751702-E97A430B-9642-49CA-B214-98AA9ACEDB88Q45932161-06D728D8-2833-45E9-94E1-227780A5B3E9Q46240818-FAAFC764-1242-4A8C-9C14-214695992B55Q48302980-F4EE1BEB-5FD4-4791-841E-50691C32A87EQ53247248-49624B18-54C3-44EF-84FB-5CF35E1FBEBE
P2860
Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
@ast
Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
@en
Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
@nl
type
label
Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
@ast
Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
@en
Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
@nl
prefLabel
Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
@ast
Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
@en
Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
@nl
P2093
P2860
P356
P1476
Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2011.93
P407
P577
2011-03-29T00:00:00Z
P5875
P6179
1039595674